{"product_id":"encompasshealth-five-forces-analysis","title":"Encompass Health Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFrom Overview to Strategy Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eEncompass Health operates in a competitive post-acute care market where buyer bargaining, reimbursement pressures, and consolidation shape margins, while regulatory hurdles and substitute care models pose notable threats. This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Encompass Health’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical labor scarcity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSpecialized therapists, nurses, and rehab physicians are core inputs and remain in short supply, elevating wage pressure and turnover risk. Reliance on travel staff and premium pay to fill gaps compresses margins and raises operating volatility. Strong employer brand and residency affiliations reduce supplier leverage by improving recruitment. Automation and scheduling efficiency help, but cannot fully offset scarcity given projected 18% demand growth for physical therapists (BLS 2022–32).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTherapy equipment and devices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTherapy equipment and devices for Encompass Health—notably rehab robotics, mobility aids and specialty devices—are sourced from a concentrated vendor base, with the global rehab robotics market estimated at about $1.2 billion in 2023. Switching costs are moderate due to staff training, protocol changes and clinical-pathway integration. Volume purchasing and device standardization can reduce supplier leverage. Supply-chain disruptions (semiconductor and component shortages) can tighten availability and raise prices.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDrugs and medical supplies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWhile many hospital supplies are commoditized, injectables and specialty medicines retain pricing power, with specialty drugs accounting for roughly half of US drug spending in 2023. Group purchasing organizations, which serve about 90% of US hospitals, improve pricing but cannot remove inflation or supply shocks. Formularies and clinical protocols help rationalize use and curb cost growth. Reliable logistics remain critical to avoid care disruptions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIT\/EMR and interoperability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEMR, analytics, and interoperability vendors create strong lock-in through proprietary data models, workflows, and regulatory compliance requirements; Epic and Oracle Cerner held roughly 60% of US hospital EMR market in 2024. Integration with referring hospitals raises switching friction, while multi-year (commonly 5–7 year) contracts and multi-million-dollar implementations amplify vendor leverage; strict cybersecurity and uptime SLAs further constrain alternatives.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eVendor concentration: Epic\/Oracle Cerner ~60% (2024)\u003c\/li\u003e\n\u003cli\u003eContract length: 5–7 years\u003c\/li\u003e\n\u003cli\u003eImplementation: multi-million-dollar\u003c\/li\u003e\n\u003cli\u003eDrive factors: data\/workflow lock-in, hospital integration, cyber\/uptime SLAs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFacility development and services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpfacility development and services: construction facilities management imaging partners materially affect encompass health cost timelines for new hospitals operated in increasing capex exposure scale needs. intensity raises dependence on a limited pool of qualified contractors regional market tightness has pushed contractor bids higher some metros. long-term service agreements can stabilize costs but reduce operational flexibility.\u003e\n\u003cp\u003e\u003c\/p\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eContractor concentration: higher bargaining power\u003c\/li\u003e\n\u003cli\u003eCapex scale: 137 hospitals (2024) increases supplier leverage\u003c\/li\u003e\n\u003cli\u003eRegional tightness: bids up ~10–15%\u003c\/li\u003e\n\u003cli\u003eLong-term contracts: cost stability vs reduced flexibility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pfacility\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinician shortages and device concentration tighten supplier power, raising wage and supply risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSupplier power is moderate-high: clinician scarcity (PT demand +18% 2022–32) and travel-staff reliance raise wage pressure and margin volatility. Device\/vendor concentration (rehab robotics ~$1.2B 2023) and EMR lock-in (Epic\/Oracle Cerner ~60% 2024) increase switching costs. GPOs (~90% hospitals) and long-term contracts mitigate but cannot remove pricing or supply shocks.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePT demand growth\u003c\/td\u003e\n\u003ctd\u003e+18% (BLS 2022–32)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRehab robotics market\u003c\/td\u003e\n\u003ctd\u003e$1.2B (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEMR share\u003c\/td\u003e\n\u003ctd\u003eEpic\/Cerner ~60% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\u003c\/td\u003e\n\u003ctd\u003e137 (Encompass 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO coverage\u003c\/td\u003e\n\u003ctd\u003e~90% US hospitals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContractor bids\u003c\/td\u003e\n\u003ctd\u003e+10–15% regional\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored exclusively for Encompass Health, this Porter's Five Forces analysis uncovers key drivers of competition, buyer and supplier influence, substitution threats, and entry barriers, highlighting disruptive trends and strategic levers that impact pricing, profitability, and market positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, one-sheet Porter's Five Forces for Encompass Health that pinpoints competitive intensity, payer\/reimbursement and regulatory risks, and supplier\/entry threats—customizable for scenario analysis and slide-ready to eliminate research and presentation bottlenecks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare and Medicaid rate setting\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedicare FFS sets the IRF base rate through the IRF PPS, effectively capping prices and limiting Encompass Health’s negotiation; CMS’s FY2024 IRF PPS update (net ~3.1% increase) and case-mix adjustments directly shift revenue. Medicaid reimbursement varies by state and is often below cost, pressuring margins. Regulatory visibility is moderate, but periodic CMS resets can produce material payment swings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare Advantage concentration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedicare Advantage enrollment topped 30 million in 2024, with top insurers capturing roughly 55–60% of enrollment in many markets, boosting plan negotiating leverage. Plans steer volume via narrow networks and prior authorization, shifting admissions and case mix. Aggressive discounts and utilization controls compress rates and length-of-stay, pressuring margins. Proven functional and readmission outcomes can earn preferred status and higher referral share.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommercial payers and ACOs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCommercial insurers and ACOs increasingly push site-of-care shifts to lower-cost alternatives and use bundled payments and value-based contracts to scrutinize post-acute spend. Contract renewals hinge on outcomes, readmissions and cost per episode, with CMS readmission penalties up to 3% reinforcing this pressure. Larger integrated systems consistently extract better commercial terms than fragmented providers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital discharge planners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHospital discharge planners act as gatekeepers for Encompass Health referrals, with acute-care placement decisions heavily swaying volumes; Encompass, the largest US post-acute provider, operated over 140 inpatient rehab hospitals in 2024, and co-located JVs demonstrably ease transfers and boost referral flow. Performance on throughput and care coordination directly changes discharge choices, so relationship management materially affects share.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGatekeeping: acute hospitals control referrals\u003c\/li\u003e\n\u003cli\u003eCo-located JVs: lower friction, higher flow\u003c\/li\u003e\n\u003cli\u003eThroughput\/care coordination: impacts placement\u003c\/li\u003e\n\u003cli\u003eRelationship management: drives volume\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatients and caregivers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIndividual patients have limited pricing power for Encompass Health because payers and clinical protocols determine coverage; in 2024 Encompass operated 137 inpatient rehab hospitals and ~257 home health\/hospice sites, keeping consumer choice bounded by location and network. Patient satisfaction and functional outcomes strongly influence referrals and reputation, while price transparency tools are growing but remain secondary to payer networks.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLow direct pricing power\u003c\/li\u003e\n\u003cli\u003eNetworks\/location limit choice\u003c\/li\u003e\n\u003cli\u003eOutcomes drive referrals\u003c\/li\u003e\n\u003cli\u003eTransparency rising but less decisive\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayers hold leverage; MA \u003cstrong\u003e\u0026gt;30M\u003c\/strong\u003e, top plans \u003cstrong\u003e~55–60%\u003c\/strong\u003e; Medicare IRF PPS \u003cstrong\u003e+3.1%\u003c\/strong\u003e risked\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePayers (Medicare FFS\/MA, Medicaid, commercial) hold strong bargaining power via rate-setting, prior auth and network steering; Medicare FY2024 IRF PPS net +3.1% but CMS resets can swing revenue. MA enrollment \u0026gt;30M (2024) with top plans at ~55–60% market share, pressuring rates and LOS. Hospitals gatekeep referrals; Encompass ran 137 IRFs and ~257 home health\/hospice sites in 2024, limiting patient choice.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMA enrollment\u003c\/td\u003e\n\u003ctd\u003e30+ million\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop plan share\u003c\/td\u003e\n\u003ctd\u003e~55–60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEncompass IRFs\u003c\/td\u003e\n\u003ctd\u003e137\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHome health\/hospice sites\u003c\/td\u003e\n\u003ctd\u003e~257\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMS FY2024 IRF PPS\u003c\/td\u003e\n\u003ctd\u003enet +3.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMS readmission penalty\u003c\/td\u003e\n\u003ctd\u003eup to 3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eEncompass Health Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Encompass Health Porter’s Five Forces analysis you'll receive immediately after purchase—no surprises or placeholders. The document is fully formatted, professionally written, and ready for download and use the moment you buy. You're viewing the final deliverable and will get instant access to this identical file upon payment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eivalry Among Competitors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Rivalry-Chart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge IRF operators\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRivalry with national and regional IRF chains, hospital JVs and specialty rehab systems is intense in overlap markets, centering on referral capture, clinical breadth and outcomes.\u003c\/p\u003e\n\u003cp\u003eScale advantages in staffing, purchasing and analytics differentiate leaders; Encompass Health, the largest post-acute provider with more than 130 IRFs and 250 home health\/hospice locations in 2024, leverages these to drive cost and quality.\u003c\/p\u003e\n\u003cp\u003eMarket leadership sustains occupancy and favorable rate mix, pressuring smaller operators.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Rivalry-Chart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital-owned rehab units\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHospital-owned IRF units let acute systems retain in-system patients, reducing transfers to post-acute providers and preserving revenue streams; Encompass Health faced competition from roughly 130+ hospital-owned IRFs in 2024. They leverage brand and care-continuity for convenience, pressuring discharges away from independent providers. JVs expand local bed capacity and intensify rivalry, while payers often negotiate favorable bundled rates with integrated systems.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Rivalry-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Rivalry-Chart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSNFs and LTACHs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSNFs (~15,000 US facilities) and LTACHs (~400–450) compete for post-acute patients across different acuity and price tiers, and payers increasingly steer lower-acuity cases to SNFs to reduce costs, pressuring IRF referrals. Strong IRF clinical criteria and outcome evidence (CMS quality metrics) defend higher-acuity placements, while local bed supply drives channel conflict.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Rivalry-Chart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality and outcome benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePublicly reported outcomes, readmissions, and patient satisfaction are pivotal levers for Encompass Health, driving referral patterns as payers and systems favor providers with stronger functional gains and discharge-to-home rates. In concentrated markets a measurable underperformance can quickly shift volume to competitors, making continuous clinical innovation and transparent reporting operational necessities. Superior outcomes directly support pricing power and network inclusion.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePublic reporting: influences referrals and payer contracts\u003c\/li\u003e\n\u003cli\u003eReadmissions: key risk to volume in concentrated markets\u003c\/li\u003e\n\u003cli\u003eDischarge-to-home: primary referral attractor\u003c\/li\u003e\n\u003cli\u003eClinical innovation: required to sustain competitive position\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Rivalry-Chart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional market dynamics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRegional rivalry shifts with state CON rules, demographics, and incumbent capacity; Encompass Health in 2024 operates over 140 inpatient rehab hospitals and ~260 home health\/hospice sites, concentrating competition in dense metros where proximity raises rivalry for therapists and patients, while rural areas face fewer rivals but thinner referral streams; local partnerships often tip local share.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMetro pressure: higher staff\/patient competition\u003c\/li\u003e\n\u003cli\u003eRural: limited rivals, lower referrals\u003c\/li\u003e\n\u003cli\u003eState CONs: barrier to entry\u003c\/li\u003e\n\u003cli\u003ePartnerships: can alter local balance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Rivalry-Chart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRehab market clash: scale, referrals and discharge-to-home outcomes drive share\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIntense rivalry centers on referral capture, outcomes and scale; Encompass Health (over 140 IRFs and ~260 home health\/hospice sites in 2024) leverages purchasing, staffing and analytics to pressure smaller operators. Competition includes ~130 hospital-owned IRFs, ~15,000 SNFs and 400–450 LTACHs; payers steer lower-acuity cases to SNFs, making outcomes and discharge-to-home rates decisive.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEncompass IRFs\u003c\/td\u003e\n\u003ctd\u003e140+\u003c\/td\u003e\n\u003ctd\u003eScale advantage\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital-owned IRFs\u003c\/td\u003e\n\u003ctd\u003e~130\u003c\/td\u003e\n\u003ctd\u003eRetention of in-system patients\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSNFs\u003c\/td\u003e\n\u003ctd\u003e~15,000\u003c\/td\u003e\n\u003ctd\u003eLower-cost diversion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLTACHs\u003c\/td\u003e\n\u003ctd\u003e400–450\u003c\/td\u003e\n\u003ctd\u003eHigh-acuity competition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eSubstitutes Threaten\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Substitutes-Arrows-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHome health and outpatient therapy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePayers increasingly favor lower-cost home-based rehab when appropriate; Medicare Advantage enrollment surpassed 30 million in 2024, intensifying pressure to shift care to home and outpatient settings. Advances in remote monitoring and tele-rehab expand candidacy for home care, reducing IRF volume. IRFs must justify higher intensity with measurable functional gains and cost-effectiveness. Care pathways and triage protocols determine substitution risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Substitutes-Arrows-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTele-rehab and digital platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRemote therapy augments or replaces parts of in‑person rehab for select cohorts; randomized trials show non‑inferior outcomes in many stroke\/orthopedic patients and the tele‑rehab market grew ~16% CAGR (2024). Digital adherence tools in pilots cut inpatient days and readmissions by single‑ to low‑double digits. Reimbursement is evolving with expanded CMS\/payer coverage; hybrid models can blunt or accelerate substitution.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Substitutes-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Substitutes-Arrows-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkilled nursing facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSkilled nursing facilities offer post-acute rehab at per-day rates roughly 30–50% lower than inpatient rehabilitation facilities, making them attractive to cost-focused payers; CMS 2024 trends show increased SNF utilization for medium-acuity cases where IRF outcomes advantage narrows. Contracting and preferred SNF networks in 2024 accelerated shifts; IRFs must emphasize acuity-appropriate value and superior functional outcomes to retain referrals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Substitutes-Arrows-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital-at-home programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eExpansion of hospital-at-home programs widens alternatives for select Encompass Health patients; by 2024 over 300 US health systems reported pilots or programs, with studies showing 20–30% lower costs and ~25% fewer readmissions. Technology and payer pilots (large insurers funding waivers) are maturing capabilities, though many IRF-level therapy\/intensity needs remain unmet and only some post-acute segments migrate; pace will follow accumulating evidence and reimbursement policy.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket penetration: 300+ US systems (2024)\u003c\/li\u003e\n\u003cli\u003eOutcomes: 20–30% lower cost; ~25% fewer readmissions\u003c\/li\u003e\n\u003cli\u003eLimitation: IRF-level intensity often not reproducible at home\u003c\/li\u003e\n\u003cli\u003eDriver: evidence and payer reimbursement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Substitutes-Arrows-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommunity wellness and prehab\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePreventive community wellness and prehab programs can lower episode severity and inpatient needs; CDC data show musculoskeletal conditions affect about 1 in 4 US adults, driving demand-side focus on prevention.\u003c\/p\u003e\n\u003cp\u003eEmployers and payers increasingly sponsor musculoskeletal and chronic care management tools, shifting care upstream and risking long-term reductions in IRF-eligible volumes while creating opportunities for providers to integrate across the continuum.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePreventive shift reduces inpatient severity and IRF referrals\u003c\/li\u003e\n\u003cli\u003eEmployer\/payer-backed MSK programs expand care management\u003c\/li\u003e\n\u003cli\u003eIntegration can reposition providers across continuum\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Substitutes-Arrows-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayers, MA and hospital-at-home squeeze IRF volumes and margins; tele-rehab, SNFs rise\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePayers and Medicare Advantage (30M enrollees in 2024) push lower-cost home\/outpatient rehab; tele‑rehab market grew ~16% CAGR to 2024 and trials show non‑inferior outcomes for many cohorts. SNFs remain 30–50% cheaper per day vs IRFs, while 300+ US systems ran hospital‑at‑home pilots in 2024 with 20–30% lower costs and ~25% fewer readmissions, pressuring IRF volume and margins.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSubstitute\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003cth\u003eImpact on IRF\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHome\/outpatient\u003c\/td\u003e\n\u003ctd\u003eMA 30M; tele‑rehab +16% CAGR\u003c\/td\u003e\n\u003ctd\u003eLower volume, payment pressure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSNF\u003c\/td\u003e\n\u003ctd\u003e30–50% lower per‑day cost\u003c\/td\u003e\n\u003ctd\u003eDeflection of medium‑acuity cases\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital‑at‑home\u003c\/td\u003e\n\u003ctd\u003e300+ systems; 20–30% cost ↓\u003c\/td\u003e\n\u003ctd\u003eSelective migration, reimbursement risk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003entrants Threaten\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Entrants-Lamp-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh capex and scale needs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIRF hospitals require multi-million-dollar capital outlays for specialized facilities, equipment, and IT, creating a high barrier to entry; Encompass Health operates a national network of over 130 hospitals, illustrating scale advantages. Economies of scale in staffing, supply purchasing, and payer contracting lower unit costs for incumbents and deter small entrants. Ramp-up to sustainable occupancy typically takes 12–24 months, allowing established networks to capitalize on cost and learning curves.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Entrants-Lamp-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and clinical barriers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCMS IRF rules, notably the 60% rule which requires 60% of admissions meet qualifying conditions, plus rigorous documentation standards, create complex compliance hurdles for entrants. Accreditation by The Joint Commission or CARF and participation in the IRF Quality Reporting Program add fixed administrative and reporting costs. Robust clinical capabilities and mandated medical director oversight are essential, so newcomers face steep setup, staffing, and governance demands.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Entrants-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Entrants-Lamp-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCertificate-of-need constraints\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCertificate-of-need (CON) laws remain in roughly 33 states in 2024, limiting bed additions and slowing market entry for providers like Encompass; CON reviews and local contests commonly extend timelines to 12–24 months. Incumbent hospitals routinely challenge applications, further delaying approvals and raising legal and lobbying costs. In CON-free states, zoning and community approvals still add friction. These regulatory barriers materially increase entry risk and can add to upfront project costs often totaling $20–40 million.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Entrants-Lamp-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWorkforce acquisition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cprecruiting experienced therapists rehab nurses and physiatrists is increasingly difficult with u.s. bureau of labor statistics projecting continued above-average demand for rehabilitation occupations through driving tighter markets higher compensation.\u003e\n\u003cplabor scarcity raises entry costs and delays ramp-up for new providers established chains like encompass health maintain recruitment pipelines in-house training that lower marginal hiring time cost.\u003e\n\u003cp\u003eNew entrants must pay hiring premiums or adopt creative staffing models (tele-rehab, travel clinicians, residency programs) to compete effectively.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigher demand: BLS projects strong growth in rehab occupations through 2032\u003c\/li\u003e\n\u003cli\u003eTurnover pressure: incumbents use training pipelines to reduce ramp-up\u003c\/li\u003e\n\u003cli\u003eEntry cost: hiring premiums and travel-staff uplift early expenses\u003c\/li\u003e\n\u003cli\u003eMitigation: telehealth and residency models lower staffing barriers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/plabor\u003e\u003c\/precruiting\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Entrants-Lamp-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayer contracts and referrals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSecuring MA\/commercial contracts and preferred discharge-planner status takes years; Medicare Advantage enrollment exceeded 30 million in 2024 (CMS), increasing payer leverage. New entrants lacking network inclusion, hospital referral relationships or outcomes history face constrained volume, and incumbent hospital JVs further tighten referral funnels.\n\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLong sales cycle\u003c\/li\u003e\n\u003cli\u003eMA\u0026gt;30M (2024)\u003c\/li\u003e\n\u003cli\u003eOutcomes history required\u003c\/li\u003e\n\u003cli\u003eIncumbent JVs restrict referrals\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Entrants-Lamp-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIRF entry: \u003cstrong\u003e$20–40M\u003c\/strong\u003e capex, \u003cstrong\u003e12–24 mo\u003c\/strong\u003e ramp, national scale barriers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIRF entry requires $20–40M capex, 12–24 month ramp and national scale—Encompass Health operates 130+ hospitals, creating scale barriers. Regulatory hurdles (CON in ~33 states, CMS 60% rule) and accreditation raise fixed costs. Labor scarcity (BLS projects above‑average rehab job growth to 2032) and payer access (Medicare Advantage \u0026gt;30M in 2024) further deter entrants.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEncompass hospitals\u003c\/td\u003e\n\u003ctd\u003e130+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCON states (2024)\u003c\/td\u003e\n\u003ctd\u003e~33\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare Advantage (2024)\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;30M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStartup capex\u003c\/td\u003e\n\u003ctd\u003e$20–40M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRamp time\u003c\/td\u003e\n\u003ctd\u003e12–24 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"PESTEL Analysis","offers":[{"title":"Default Title","offer_id":58097786126684,"sku":"encompasshealth-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0938\/8127\/0620\/files\/encompasshealth-five-forces-analysis.png?v=1781793230","url":"https:\/\/pestel-analysis.com\/products\/encompasshealth-five-forces-analysis","provider":"PESTEL ANALYSIS","version":"1.0","type":"link"}